2may demonstrate that a case is “exceptional” include willful infringement, bad faith, litigation misconduct,and unprofessional behavior.
Sensonics, Inc. v. Aerosonic Corp.
, 81 F.3d 1566, 1674 (Fed. Cir. 1996).In addition, “inequitable conduct may constitute a basis for an award of attorney fees under 35U.S.C. § 285.”
Osram
, 528 F.3d at 138 (quoting
A.B. Chance Co. v. RTE Corp.
, 854 F.2d 1307, 1312(Fed. Cir. 1988)). As the Federal Circuit noted in its recent
Osram
holding, however, “there is no
per se
rule of exceptionality in cases involving inequitable conduct.”
Osram
, 528 F.3d at 138. The court furtherrecognized that it had on many occasions affirmed a district court’s denial of attorney fees in casesinvolving inequitable conduct, and had likewise affirmed the courts’ decisions to award attorney fees onthe basis of inequitable conduct.
Id.
(collecting cases and stating, “In short, our case law provides widediscretion to district courts; courts may award attorney fees in inequitable conduct cases, but are notrequired to do so.”).The Federal Circuit has also made it clear that a prior finding of inequitable conduct by a differentcourt in an action involving the same plaintiff and the same patents will have a preclusive effect insubsequent proceedings. In
Upjohn Co. v. Mova Pharm. Corp.
, 31 F. Supp. 2d 211 (D.P.R. 1998), a jurydetermined that the defendant had proved by clear and convincing evidence that the subject patent wasinvalid as obvious under 35 U.S.C. § 103, and unenforceable due to the plaintiff’s inequitable conduct.Upjohn subsequently filed a motion for judgment as a matter of law (“JMOL”) or, alternatively, for a newtrial. While that motion was pending, a different district court in a different case involving the sameplaintiff granted summary judgment for the defendant, based in part upon its collateral application of the
Mova
judgments of invalidity and unenforceability. The Federal Circuit affirmed.
Pharmacia & Upjohn Co. v. Mylan Pharm., Inc.
, 170 F.3d 1373 (Fed. Cir. 1999) (“
Mylan I
”). After the
Mova
district court deniedthe JMOL motion, the
Mylan
district court denied the defendant’s motion for attorney fees, expresslyfinding that the plaintiff’s litigation tactics were in good faith and raised genuine issues of patentinfringement. It therefore found that the case was not an exceptional one meriting a fee award.
Pharmacia & Upjohn Co. v. Mylan Pharm., Inc.
, No. 1:97-CV-41 (N.D. W. Va. Aug. 17, 1998). Thedefendant appealed the district court’s denial of its motion for attorney fees, arguing that the district courthad erred in failing to consider the outcome of
Mova
.
Case 3:04-cv-00080 Document 217 Filed 01/27/2009 Page 2 of 7
Add a Comment